| Save 25% on a pre-paid one year subscription. |
|
|
 2 |
Filed: 12/27/2016, Entered: None |
Unknown Document Type |
|
Disclosure Statement Form pursuant to FRCP 7.1 by ROCHESTER DRUG CO-OPERATIVE, INC.(jmv, ) (Entered: 12/29/2016)
|
|
 Request |
 |
|
|
| 1 |
Filed: 12/27/2016, Entered: None |
Unknown Document Type |
|
COMPLAINT against FOUGERA PHARMACEUTICALS, INC., PERRIGO COMPANY PLC, TARO PHARMACEUTICAL INDUSTRIES LTD., TARO PHARMACEUTICALS USA, INC., TELIGENT, INC. ( Filing fee $ 400 receipt number PPE152303.), filed by ROCHESTER DRUG CO-OPERATIVE, INC.. (Attachments: # 1 Complaint Part 2, # 2 Civil Cover Sheet, # 3 Designation Form, # 4 Case Management Track Form)(jmv, ) (Entered: 12/28/2016)
|
|
Request |
|
|
|
| 19 |
Filed: 2/21/2019, Entered: 2/22/2019 |
|
|
PRETRIAL ORDER NO. 77 THAT THE CASES LISTED IN APPENDIX A SHALL BE PLACED IN CIVIL SUSPENSE FOR STATISTICAL PURPOSES UNTIL FURTHER ORDER OF THE COURT.. SIGNED BY HONORABLE CYNTHIA M. RUFE ON 2/21/2019. 2/22/2019 ENTERED AND COPIES E-MAILED TO LIAISON COUNSEL. (SEE DOCKET NO 874 IN 16-MD-2724)(kp, )
|
|
Request |
|
|
|
| 18 |
Filed: 2/22/2018, Entered: 2/22/2018 |
|
|
ORDER THAT THE CLAIMS OF OMITTED PLAINTIFFS IN THE INDIVIDUAL CASES LISTED IN APPENDIX A ARE VOLUNTARILY DISMISSED WITHOUT PREJUDICE PURSUANT TO F.R.C.P. 41(a)(1)(A)(ii); ALL CLAIMS AGAINST THE OMITTED DEFENDANTS WITH RESPECT TO THE PHARMACEUTICAL PRODUCT(S) AT ISSUE IN THE CASES LISTED IN APPENDIX B ARE VOLUNTARILY DISMISSED WITHOUT PREJUDICE PURSUANT TO F.R.C.P. 41(a)(1)(A)(ii); THIS ORDER SHALL HAVE NO EFFECT ON ANY TOLLING AGREEMENTS EXECUTED PRIOR TO THE DATE OF THIS ORDER, ETC. SIGNED BY HONORABLE CYNTHIA M. RUFE ON 2/22/2018; 2/22/2018 ENTERED AND COPIES E-MAILED TO LIAISON COUNSEL. (SEE PAPER # 569 IN 16-MD-2724). (tjd)
|
|
Request |
|
|
|
| 17 |
Filed: 4/10/2017, Entered: 4/11/2017 |
|
|
PRETRIAL ORDER NO. 12 THAT THE ABOVE-CAPTIONED CASES, ALREADY ASSIGNED TO THIS COURT'S CALENDAR, SHALL BE MADE PART OF IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION, 16-MD-2724, FOR COORDINATED AND CONSOLIDATED PRETRIAL PROCEEDINGS. IT IS FURTHER ORDERED THAT, EFFECTIVE THIS DATE, ALL CASES THAT ARE FILED DIRECTLY INTO THE MDL PURSUANT TO PRETRIAL ORDER NO. 1 SHALL LIST ON THE CIVIL COVER SHEET WITH THE RELATED CASE DESIGNATION THE GENERIC DRUG(S) UPON WHICH SUIT IS BROUGHT. SIGNED BY HONORABLE CYNTHIA M. RUFE ON 4/10/2017. 4/11/2017 ENTERED AND COPIES MAILED AND E-MAILED TO LIAISON COUNSEL. (SEE PAPER # 195 IN 16-MD-2724) (ems)
|
|
Request |
|
|
|
| 16 |
Filed: 2/7/2017, Entered: 2/8/2017 |
|
|
ORDER THAT THE ATTACHED STIPULATION TO SET DEADLINES FOR RESPONSIVE PLEADINGS IS APPROVED. DEFENDANTS' TIME TO ANSWER, MOVE OR OTHERWISE RESPOND TO PLAINTIFF'S COMPLAINT SHALL BE EXTENDED UNTIL AFTER DISPOSITION OF THE JPML PROCEEDING. ADDITIONAL INFORMATION CONTAINED HEREIN. SIGNED BY HONORABLE CYNTHIA M. RUFE ON 2/7/2017. 2/8/2017 ENTERED AND COPIES E-MAILED. (aeg)
|
|
Request |
|
|
|
| 15 |
Filed: 2/1/2017, Entered: 2/1/2017 |
|
|
ORDER THAT THE APPLICATION FOR PRO HAC VICE ADMISSION OF LAURA SHORES, ESQUIRE, IS GRANTED. SIGNED BY HONORABLE CYNTHIA M. RUFE ON 2/1/2017. 2/1/2017 ENTERED AND COPIES E-MAILED.(amas)
|
|
Request |
|
|
|
| 14 |
Filed: 2/1/2017, Entered: 2/1/2017 |
|
|
ORDER THAT THE APPLICATION FOR PRO HAC VICE ADMISSION OF MARGARET ROGERS, ESQUIRE, IS GRANTED. SIGNED BY HONORABLE CYNTHIA M. RUFE ON 2/1/2017. 2/1/2017 ENTERED AND COPIES E-MAILED.(amas)
|
|
Request |
|
|
|
| 13 |
Filed: 2/1/2017, Entered: 2/1/2017 |
|
|
ORDER THAT THE APPLICATION FOR PRO HAC VICE ADMISSION OF SAUL P. MORGENSTERN, ESQUIRE, IS GRANTED. SIGNED BY HONORABLE CYNTHIA M. RUFE ON 2/1/2017. 2/1/2017 ENTERED AND COPIES E-MAILED.(amas)
|
|
Request |
|
|
|
| 12 |
Filed: 1/31/2017, Entered: 1/31/2017 |
|
|
NOTICE of Appearance by DAVID F. SORENSEN on behalf of ROCHESTER DRUG CO-OPERATIVE, INC. with Certificate of Service(SORENSEN, DAVID)
|
|
Request |
|
|
|
| 11 |
Filed: 1/31/2017, Entered: 1/31/2017 |
|
|
NOTICE of Appearance by ZACHARY D. CAPLAN on behalf of ROCHESTER DRUG CO-OPERATIVE, INC. with Certificate of Service(CAPLAN, ZACHARY)
|
|
Request |
|
|
|
| 10 |
Filed: 1/30/2017, Entered: 1/31/2017 |
|
|
APPLICATION FOR PRO HAC VICE ADMISSION OF LAURA SHORES, ESQUIRE ON BEHALF OF FOUGERA PHARMACEUTICALS, INC. SPONSER STATEMENT, CERTIFICATE OF SERVICE. (FEE PAID 1/30/2017) (amas)
|
|
Request |
|
|
|
| 9 |
Filed: 1/30/2017, Entered: 1/31/2017 |
|
|
APPLICATION FOR PRO HAC VICE ADMISSION OF MARGARET ROGERS, ESQUIRE ON BEHALF OF FOUGERA PHARMACEUTICALS, INC. SPONSER STATEMENT, CERTIFICATE OF SERVICE. (FEE PAID 1/30/2017) (amas)
|
|
Request |
|
|
|
| 8 |
Filed: 1/30/2017, Entered: 1/31/2017 |
|
|
APPLICATION FOR PRO HAC VICE ADMISSION OF SAUL P. MORGENSTERN, ESQUIRE ON BEHALF OF FOUGERA PHARMACEUTICALS, INC. SPONSER STATEMENT, CERTIFICATE OF SERVICE. (FEE PAID 1/30/2017) (amas)
|
|
Request |
|
|
|
| 7 |
Filed: 1/27/2017, Entered: 1/27/2017 |
|
|
NOTICE of Appearance by PETER MICHAEL RYAN on behalf of FOUGERA PHARMACEUTICALS, INC. with Certificate of Service(RYAN, PETER)
|
|
Request |
|
|
|
| 6 |
Filed: 1/26/2017, Entered: 1/26/2017 |
|
|
Disclosure Statement Form pursuant to FRCP 7.1 with Certificate of Service by FOUGERA PHARMACEUTICALS, INC..(SACUNAS, ABBY)
|
|
Request |
|
|
|
| 5 |
Filed: 1/26/2017, Entered: 1/26/2017 |
|
|
NOTICE of Appearance by ABBY L. SACUNAS on behalf of FOUGERA PHARMACEUTICALS, INC. with Certificate of Service(SACUNAS, ABBY)
|
|
Request |
|
|
|
| 4 |
Filed: 1/3/2017, Entered: 1/3/2017 |
|
|
ORDER THAT AS THESE CASES DO NOT ALLEGE ANTITRUST VIOLATIONS WITH REGARD TO GENERIC DIGOXIN OR DOXYCYCLINE, THEY ARE NOT PROPERLY FILED IN MDL 2724 AS PRESENTLY CONSTRUCTED. THEREFORE, THE CLERK IS DIRECTED TO REMOVE THE MDL 2724 DESIGNATION FROM THESE CASES PENDING A DECISION BY THE JUDICIAL PANEL ON MULTIDISTRICT LITIGATION ("JPML") WITH REGARD TO THE MOTION OF PLAINTIFF ROCHESTER DRUG COOPERATIVE FOR TRANSFER OF RELATED ACTIONS. IT IS FURTHER ORDERED THAT FOR PURPOSES OF JUDICIAL ADMINISTRATION, THE ABOVE-CAPTIONED CASES SHALL BE MARKED AS RELATED TO THE FIRST CASE FILED IN THIS COURT AS PART OF THE MDL, INTERNATIONAL UNION OF OPERATING ENGINEERS LOCAL 30 BENEFITS FUND v. LANNETT COMPANY, INC., CIVIL ACTION NO. 16-990, AND REMAIN AS PRESENTLY ASSIGNED PENDING FURTHER ORDER OF THIS COURT OR THE JPML. SIGNED BY HONORABLE CYNTHIA M. RUFE ON 1/3/2017. 1/3/2017 ENTERED AND COPIES MAILED AND E-MAILED TO LIAISON COUNSEL. (SEE PAPER # 101 IN 16-MD-2724) (ems)
|
|
Request |
|
|
|
| 3 |
Filed: 12/29/2016, Entered: 12/29/2016 |
|
|
ORDER REFERRING CASE TO ARBITRATION AND APPOINTING ANDREW OMINSKY, ESQ. (CHAIR); KARL S. MYERS, ESQ. AND GEORGE A. FIELDCAMP, ESQ. AS ARBITRATORS ON 2/1/17, ETC. SIGNED BY HONORABLE MARK A. KEARNEY ON 12/28/16. 12/29/16 ENTERED AND COPIES E-MAILED.(jmv, ) (FILED IN ERROR)
|
|
Request |
|
|
|
| 2 |
Filed: 12/27/2016, Entered: 12/29/2016 |
|
|
Disclosure Statement Form pursuant to FRCP 7.1 by ROCHESTER DRUG CO-OPERATIVE, INC.(jmv, )
|
|
Request |
|
|
|
| |
Filed: 12/27/2016, Entered: 12/28/2016 |
|
|
DEMAND for Trial by Jury by ROCHESTER DRUG CO-OPERATIVE, INC.. (jmv, )
|
|
|
|
|
|
| |
Filed: 12/27/2016, Entered: 12/28/2016 |
|
|
Summons Issued as to FOUGERA PHARMACEUTICALS, INC., PERRIGO COMPANY PLC, TARO PHARMACEUTICAL INDUSTRIES LTD., TARO PHARMACEUTICALS USA, INC., TELIGENT, INC.. Forwarded To: 5 Origs mailed to counsel on 12/28/16 (jmv, )
|
|
|
|
|
|
| 1 |
Filed: 12/27/2016, Entered: 12/28/2016 |
|
|
COMPLAINT against FOUGERA PHARMACEUTICALS, INC., PERRIGO COMPANY PLC, TARO PHARMACEUTICAL INDUSTRIES LTD., TARO PHARMACEUTICALS USA, INC., TELIGENT, INC. ( Filing fee $ 400 receipt number PPE152303.), filed by ROCHESTER DRUG CO-OPERATIVE, INC.. (Attachments: # 1 Complaint Part 2, # 2 Civil Cover Sheet, # 3 Designation Form, # 4 Case Management Track Form)(jmv, )
|
|
Request |
|
Update
Alerts
Jump